For: | Yang XQ, Ye J, Li X, Li Q, Song YH. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes. World J Gastroenterol 2019; 25(28): 3753-3763 [PMID: PMC6676551 DOI: 10.3748/wjg.v25.i28.3753] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v25/i28/3753.htm |
Number | Citing Articles |
1 |
Sai Li, Yong Li, Chunhui Zhou, Haiping Li, Changyong Chen, Changli Peng, Tianming Wang, Fei Liu, Juxiong Xiao, Liangrong Shi. Transjugular Intrahepatic Portosystemic Shunt Benefits for Hepatic Sinusoidal Obstruction Syndrome Associated with Consumption of Gynura Segetum: a Propensity Score-Matched Analysis. CardioVascular and Interventional Radiology 2023; 46(7): 931 doi: 10.1007/s00270-023-03451-9
|
2 |
Jianzuo Yao, Jingyi Wu, Shu Jia, Jingping Shao, Xie Zhang, Zeping Xu, Hui Zhang, Hong Li, Xiaomin Yao. Effects of bicyclol on hepatic sinusoidal obstruction syndrome induced by Gynura segetum. Journal of Clinical Laboratory Analysis 2022; 36(12) doi: 10.1002/jcla.24793
|
3 |
Yasuyuki Naito, Yuka Yoshinouchi, Yukiko Sorayama, Hiroshi Kohara, Shiro Kitano, Shinji Irie, Michiya Matsusaki. Constructing vascularized hepatic tissue by cell-assembled viscous tissue sedimentation method and its application for vascular toxicity assessment. Acta Biomaterialia 2022; 140: 275 doi: 10.1016/j.actbio.2021.11.027
|
4 |
Xuefeng Luo, Oana Nicoară-Farcău, Marta Magaz, Fabian Betancourt, Guillem Soy, Anna Baiges, Fanny Turon, Virginia Hernández-Gea, Juan Carlos García-Pagán. Cardio-Hepatology. 2023; : 65 doi: 10.1016/B978-0-12-817394-7.00004-8
|
5 |
Xiaofei Du, Zhenli Liu, Haibin Yu, Yu Wang, Zhengsheng Zou, Hongshan Wei, Jing Liang, Daokun Yang, Yali Liu, Jing Zhang, Calvin Q. Pan. Prognostic risk factors for patients with hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloids. Medicine 2023; 102(32): e34698 doi: 10.1097/MD.0000000000034698
|
6 |
Yan-yun Shu, Li-lin Hu, Ling Yang, Hui-kuan Chu, Jin Ye, Yu Jin. Rifaximin Prevents Intestinal Barrier Dysfunction and Alleviates Liver Injury in MCT-induced HSOS Mice. Current Medical Science 2023; 43(6): 1183 doi: 10.1007/s11596-023-2801-y
|
7 |
|
8 |
Ruiqi Li, Lin Li, Zihao Cai, Jun Chen, Han Zhang, Si Zhao, Jingjing Tu, Chang Sun, Yani Jin, Ming Zhang, Feng Zhang, Wei Zhang, Qin Yin, Hui Xu, Hao Han, Taishun Li, Yuzheng Zhuge, Jiangqiang Xiao. Histological evaluation of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: Correlation with Drum Tower Severity Scoring. Digestive and Liver Disease 2024; 56(7): 1220 doi: 10.1016/j.dld.2023.12.008
|
9 |
Jun-Hong Liu, Han Yang, Ling Zhang, Xing-Rong Peng, Zhen-Jie Li, Mei-Ying He, Luo-Sheng Wan, Zhong-Rong Li, Lin Zhou, Zhi-Hua Liu, Ming-Hua Qiu. Pyrrolizidine alkaloids from the seeds of Scleropyrum wallichianum. Journal of Asian Natural Products Research 2021; 23(5): 407 doi: 10.1080/10286020.2020.1740919
|
10 |
Ziqi Wang, Haolei Han, Chen Wang, Qinqin Zheng, Hongping Chen, Xiangchun Zhang, Ruyan Hou. Hepatotoxicity of Pyrrolizidine Alkaloid Compound Intermedine: Comparison with Other Pyrrolizidine Alkaloids and Its Toxicological Mechanism. Toxins 2021; 13(12): 849 doi: 10.3390/toxins13120849
|
11 |
Fan Wu, Jiao Yu, Hongying Gan, Heng Zhang, Deying Tian, Dan Zheng. Timing and efficacy of transjugular intrahepatic portosystemic shunt in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-01201-w
|
12 |
Yimin Mao, Shiwu Ma, Chenghai Liu, Xiaoyan Liu, Minghua Su, Dongliang Li, Yiling Li, Gongying Chen, Jun Chen, Jinjun Chen, Jingmin Zhao, Xiaoyan Guo, Jieting Tang, Yuzheng Zhuge, Qing Xie, Wen Xie, Rongtao Lai, Dachuan Cai, Qingxian Cai, Yang Zhi, Xiaoyun Li. Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update. Hepatology International 2024; 18(2): 384 doi: 10.1007/s12072-023-10633-7
|
13 |
Gongzhen Chen, Leiming Mao, Huyan Xia, Lei Zhu, Jiamin Huang, Yingmin Lu, Xin Liu, Ting Tang. Analysis of potential risks of clinical application of Yi Dian Hong and its proprietary Chinese medicines: A review. Medicine 2024; 103(4): e36860 doi: 10.1097/MD.0000000000036860
|
14 |
Prodromos Hytiroglou, Matthew M. Yeh. MacSween's Pathology of the Liver. 2024; : 687 doi: 10.1016/B978-0-7020-8228-3.00011-9
|
15 |
Yasuyuki Naito, Yuka Yoshinouchi, Yukiko Sorayama, Hiroshi Kohara, Shiro Kitano, Shinji Irie, Michiya Matsusaki. Constructing Vascularized Hepatic Tissue by Cell Assembled Viscous Tissue Sedimentation Method and Its Application for Vascular Toxicity Assessment. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3906842
|
16 |
Jia-Yun Jiang, Yu Fu, Yan-Jiao Ou, Lei-Da Zhang. Hepatic sinusoidal obstruction syndrome induced by tacrolimus following liver transplantation: Three case reports. World Journal of Clinical Cases 2022; 10(36): 13408-13417 doi: 10.12998/wjcc.v10.i36.13408
|
17 |
Youwen Tan, Xingbei Zhou. Anticoagulant therapy likely increases risk of bleeding in Gynura segetum-induced hepatic sinus obstruction syndrome. Medicine 2024; 103(6): e35914 doi: 10.1097/MD.0000000000035914
|
18 |
Jiang Ma, Mi Li, Na Li, Wood Yee Chan, Ge Lin. Pyrrolizidine Alkaloid-Induced Hepatotoxicity Associated with the Formation of Reactive Metabolite-Derived Pyrrole–Protein Adducts. Toxins 2021; 13(10): 723 doi: 10.3390/toxins13100723
|
19 |
Yang Cheng, Lihong Gu, Xiaochun Yin, Xixuan Wang, Jiangqiang Xiao, Yi Wang, Wei Zhang, Lei Wang, Xiaoping Zou, Ming Zhang, Yuzheng Zhuge, Feng Zhang. Agreement between Wedged Hepatic Venous Pressure and Portal Pressure in Hepatic Sinusoidal Obstruction Syndrome. Journal of Personalized Medicine 2022; 13(1): 4 doi: 10.3390/jpm13010004
|
20 |
Ziad Chebaro, Adnan Badran, Marc Maresca, Elias Baydoun, Joelle Edward Mesmar. Ethnopharmacology and therapeutic potential of Anchusa strigosa: a comprehensive review. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1301154
|
21 |
Xunjiang Wang, Wei Zhang, Yongfeng Yang, Yiran Chen, Yuzheng Zhuge, Aizhen Xiong, Li Yang, Zhengtao Wang. Blood microRNA Signatures Serve as Potential Diagnostic Biomarkers for Hepatic Sinusoidal Obstruction Syndrome Caused by Gynura japonica Containing Pyrrolizidine Alkaloids. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.627126
|
22 |
Yu-Guan Xie, Chen Xu, Hai-Bin Shi, Sheng Liu, Wei Yang, Wei Tian, Wei-Zhong Zhou. Transjugular intrahepatic portosystemic shunt for pyrrolidine-alkaloid-induced hepatic sinusoidal obstruction syndrome in a patient with situs inversus totalis and portal vein thrombus. International Journal of Gastrointestinal Intervention 2023; 12(1): 46 doi: 10.18528/ijgii220055
|
23 |
Youwen Tan, Sainan Zheng. Clinicopathological characteristics and diagnosis of hepatic sinusoidal obstruction syndrome caused by Tusanqi – Case report and literature review. Open Medicine 2023; 18(1) doi: 10.1515/med-2023-0737
|
24 |
Xiaoxiang Sun, Zhengyuan Xie, Zheng He, Yisheng He, Zigao Zhao, Xuerong Yan, Xiangjing Song, Zijie Chen, Tao Wang, Quanrui Yue, Yiming Chen, Hanfeng Ye, Ge Lin, Hui Wang, Yu Guo. Association between pyrrolizidine alkaloids exposure and risk of abnormal serum indices—Insights from a descriptive cross-sectional study in Yunnan Province. Journal of Hazardous Materials 2024; 480: 136352 doi: 10.1016/j.jhazmat.2024.136352
|
25 |
Panpan Cen, Jiexia Ding, Jie Jin. Hepatic sinusoidal obstruction syndrome caused by the ingestion of Gynura segetum in a patient with alcoholic cirrhosis: a case report. Journal of International Medical Research 2021; 49(4) doi: 10.1177/0300060520980649
|
26 |
Chaoyang Wang, Yingliang Wang, Jianbo Zhao, Chongtu Yang, Xiaoli Zhu, Huanzhang Niu, Junhui Sun, Bin Xiong. Transjugular intrahepatic portosystemic shunt for the treatment of hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloids: A multicenter retrospective study. Heliyon 2024; 10(1): e23455 doi: 10.1016/j.heliyon.2023.e23455
|
27 |
Marta Magaz, Juan Carlos García-Pagán. Risk factors of poor prognosis in patients with pyrrolidine alkaloids induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt. Hepatology International 2021; 15(3): 568 doi: 10.1007/s12072-021-10166-x
|
28 |
Qianxin Huang, Qingqiao Zhang, Hao Xu, Maoheng Zu, Jinchang Xiao, Bin Shen. Mid- to long-term outcomes of initial transjugular intrahepatic portosystemic shunt versus anticoagulation for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. European Journal of Gastroenterology & Hepatology 2023; 35(4): 445 doi: 10.1097/MEG.0000000000002509
|
29 |
Feifei Lin, Yan Ma, Anni Pan, Yang Ye, Jia Liu. Quantification of Usaramine and its N-Oxide Metabolite in Rat Plasma Using Liquid Chromatography-Tandem Mass Spectrometry. Journal of Analytical Toxicology 2022; 46(5): 512 doi: 10.1093/jat/bkab060
|
30 |
Rolf Teschke, Xingshun Qi, Tran Dang Xuan, Axel Eickhoff. Treatment and Management of Tropical Liver Disease. 2025; : 182 doi: 10.1016/B978-0-323-87031-3.00031-7
|
31 |
Feng Dai, Wei Qiao, Zheng Kang, Yan Chen, Kang Li, Wenrong Shen, Xiuming Zhang. Clinical Features and CT Imaging Analysis of Hepatic Sinuscase-Syndrome and Budd–Chiari Syndrome. International Journal of General Medicine 2022; : 2389 doi: 10.2147/IJGM.S348176
|
32 |
Haitao Shang, Chao Huang, Zhuanglong Xiao, Pengcheng Yang, Shengyan Zhang, Xiaohua Hou, Lei Zhang. Gut microbiota-derived tryptophan metabolites alleviate liver injury via AhR/Nrf2 activation in pyrrolizidine alkaloids-induced sinusoidal obstruction syndrome. Cell & Bioscience 2023; 13(1) doi: 10.1186/s13578-023-01078-4
|
33 |
Zaoqin Yu, Wei Li, Cheng Tian, Yan Cao, Chengliang Zhang. Drug-induced hepatic sinusoidal obstruction syndrome: current advances and future perspectives. Archives of Toxicology 2025; 99(3): 835 doi: 10.1007/s00204-024-03950-9
|
34 |
Hui Zhang, Shu Jia, Lianyu Jin, Jianzuo Yao MB, Zhihong Shen, Jingyi Wu, Xiaokun Yao, Danwei Chen, Congcong Zhang, Shufang Yu, Ningwei Zhu, Lexiao Jin, Xiaomin Yao. Gynura segetum induces hepatic sinusoidal obstruction syndrome in mice by impairing autophagy. Acta Cirúrgica Brasileira 2021; 36(11) doi: 10.1590/acb361104
|
35 |
Parthiban Durairaj, M. Senthil, Anand Bharathan, M. Mariappan. Tacrolimus-induced Sinusoidal Obstruction Syndrome after Liver Transplant: A Report of a Rare Case. Indian Journal of Transplantation 2024; 18(1): 96 doi: 10.4103/ijot.ijot_97_23
|
36 |
Minjie Jiang, Luyuan Wang, Xiaodong Du, Miaomiao Hao, Pujun Gao. Low molecular weight heparin in the treatment of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: five case reports. Journal of International Medical Research 2020; 48(9) doi: 10.1177/0300060520961916
|
37 |
Xuan Wang, Wei Zhang, Ming Zhang, Feng Zhang, Jiangqiang Xiao, Qin Yin, Hao Han, Taishun Li, Ge Lin, Yuzheng Zhuge. Development of a Drum Tower Severity Scoring (DTSS) system for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. Hepatology International 2022; 16(3): 669 doi: 10.1007/s12072-021-10293-5
|
38 |
Tongmin Huang, Xingfen Zhang, Kun Yan, Dandi Lou, Yujing He, Senjie Dai, Dingcheng Zheng, Ping Chen, Feng Wu, Lihu Gu. Transjugular intrahepatic portosystemic shunt for pyrrolidine alkaloids-induced hepatic sinusoidal obstruction syndrome: a retrospective cohort study. European Journal of Gastroenterology & Hepatology 2023; 35(9): 1004 doi: 10.1097/MEG.0000000000002591
|
39 |
Ziqi Wang, Liang Qiao, Qinqin Zheng, Haolei Han, Zuguang Li, Xiangchun Zhang, Hongping Chen. Combined Hepatotoxicity and Toxicity Mechanism of Intermedine and Lycopsamine. Toxins 2022; 14(9): 633 doi: 10.3390/toxins14090633
|
40 |
Jiangqiang Xiao, Jingjing Tu, Han Zhang, Feng Zhang, Wei Zhang, Hui Xu, Qin Yin, Jian Yang, Hao Han, Yi Wang, Bin Zhang, Chunyan Peng, Xiaoping Zou, Ming Zhang, Yuzheng Zhuge. Risk factors of poor prognosis in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt. Hepatology International 2021; 15(3): 720 doi: 10.1007/s12072-020-10126-x
|
41 |
Feifei Lu, Siqi Jia, Huiyuan Lu, Haonan Zhao, Zhe Li, Yuzheng Zhuge, Fernando Gomes Romeiro, Nahum Mendez-Sanchez, Xingshun Qi. Primary Budd-Chiari syndrome versus sinusoidal obstruction syndrome: a review. Current Medical Research and Opinion 2024; 40(2): 303 doi: 10.1080/03007995.2023.2288909
|
42 |
Qian Zheng, Haiyang Zhang. Gynura segetum induces hepatic sinusoidal obstruction syndrome in a child: A case report. Medicine 2024; 103(11): e37341 doi: 10.1097/MD.0000000000037341
|
43 |
Yu-Hu Song, Hong-Yu Xiang, Ke-Ke Si, Ze-Hui Wang, Yu Zhang, Chang Liu, Ke-Shu Xu, Xin Li. Difference between type 2 gastroesophageal varices and isolated fundic varices in clinical profiles and portosystemic collaterals. World Journal of Clinical Cases 2022; 10(17): 5620-5633 doi: 10.12998/wjcc.v10.i17.5620
|
44 |
Hongyu Xiang, Chang Liu, Zhuanglong Xiao, Li Du, Ning Wei, Fang Liu, Yuhu Song. Enoxaparin attenuates pyrrolizidine alkaloids‐induced hepatic sinusoidal obstruction syndrome by inhibiting oncostatin M expression. Liver International 2023; 43(3): 626 doi: 10.1111/liv.15475
|
45 |
|
46 |
John A. Edgar, Russell J. Molyneux, Steven M. Colegate. 1,2-Dehydropyrrolizidine Alkaloids: Their Potential as a Dietary Cause of Sporadic Motor Neuron Diseases. Chemical Research in Toxicology 2022; 35(3): 340 doi: 10.1021/acs.chemrestox.1c00384
|
47 |
Zhenlin Huang, Zeqi Wu, Xinnan Gu, Lili Ji. Diagnosis, toxicological mechanism, and detoxification for hepatotoxicity induced by pyrrolizidine alkaloids from herbal medicines or other plants. Critical Reviews in Toxicology 2024; 54(2): 123 doi: 10.1080/10408444.2024.2310597
|
48 |
Yong Lv, Daiming Fan, Guohong Han. Transjugular intrahepatic portosystemic shunt for portal hypertension: 30 years experience from China. Liver International 2023; 43(1): 18 doi: 10.1111/liv.15313
|
49 |
Zhenlin Huang, Zeqi Wu, Jingnan Zhang, Keke Wang, Qing Zhao, Minwei Chen, Shihao Yan, Qian Guo, Yun Ma, Lili Ji. Andrographolide attenuated MCT-induced HSOS via regulating NRF2-initiated mitochondrial biogenesis and antioxidant response. Cell Biology and Toxicology 2023; 39(6): 3269 doi: 10.1007/s10565-023-09832-7
|
50 |
Yaru Tong, Ming Zhang, Zexue Qi, Wei Wu, Jinjun Chen, Fuliang He, Hao Han, Pengxu Ding, Guangchuan Wang, Yuzheng Zhuge. Hepatic Venous Occlusion Type of Budd–Chiari Syndrome versus Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstructive Syndrome: A Multi-Center Retrospective Study. Journal of Personalized Medicine 2023; 13(4): 603 doi: 10.3390/jpm13040603
|
51 |
Rolf Teschke, Noudeng Vongdala, Nguyen Van Quan, Tran Ngoc Quy, Tran Dang Xuan. Metabolic Toxification of 1,2-Unsaturated Pyrrolizidine Alkaloids Causes Human Hepatic Sinusoidal Obstruction Syndrome: The Update. International Journal of Molecular Sciences 2021; 22(19): 10419 doi: 10.3390/ijms221910419
|
52 |
Xiaoqian Yang, Ping Lei, Yuhu Song, Zhenyu Fei, Yan Ai, Haitao Shang, Tao Bai, Jin Ye, Xin Li. Quantitative CT assessment by histogram and volume ratio in pyrrolizidines alkaloids-induced hepatic sinusoidal obstruction syndrome. European Journal of Radiology 2021; 138: 109632 doi: 10.1016/j.ejrad.2021.109632
|
53 |
Ying Liu, Li-Ying Sun, Zhi-Jun Zhu, Lin Wei, Wei Qu, Zhi-Gui Zeng. Is sinusoidal obstructive syndrome a recurrent disease after liver transplantation? A case report . World Journal of Clinical Cases 2021; 9(2): 489-495 doi: 10.12998/wjcc.v9.i2.489
|
54 |
Chengxiong Zhang, Zehui Wu, Fengping Wang, Lianghui Shi. Hepatic sinusoidal obstruction syndrome after oral intake of Gynura segetum. Asian Journal of Surgery 2021; 44(7): 991 doi: 10.1016/j.asjsur.2021.04.015
|
55 |
Ana Catarina Sousa, Cláudia Ribeiro, Virgínia M.F. Gonçalves, Inês Pádua, Sandra Leal. Chromatographic Methods for Detection and Quantification of Pyrrolizidine Alkaloids in Flora, Herbal Medicines, and Food: An Overview. Critical Reviews in Analytical Chemistry 2024; 54(8): 2915 doi: 10.1080/10408347.2023.2218476
|
56 |
Adelina Staicu, Roxana Popa-Stanila, Camelia Albu, Alexandra Chira, Roxana Constantin, Dan Boitor-Borza, Mihai Surcel, Ioana Cristina Rotar, Gheorghe Cruciat, Daniel Muresan. Neonatal Hemochromatosis: Systematic Review of Prenatal Ultrasound Findings—Is There a Place for MRI in the Diagnostic Process?. Journal of Clinical Medicine 2023; 12(7): 2679 doi: 10.3390/jcm12072679
|
57 |
Josephin Glück, Marcus Henricsson, Albert Braeuning, Stefanie Hessel-Pras. The Food Contaminants Pyrrolizidine Alkaloids Disturb Bile Acid Homeostasis Structure-Dependently in the Human Hepatoma Cell Line HepaRG. Foods 2021; 10(5): 1114 doi: 10.3390/foods10051114
|
58 |
Fang Liu, Xinxin Rong, Hui Guo, Dong Xu, Chang Liu, Lingling Meng, Xiaoqian Yang, Tingting Guo, Xuefeng Kan, Yuhu Song. Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-1180-0
|
59 |
David Ricardo da Conceição Marçal Alves Nunes, Cristina Sofia de Jesus Monteiro, Jorge Luiz dos Santos. Herb-Induced Liver Injury—A Challenging Diagnosis. Healthcare 2022; 10(2): 278 doi: 10.3390/healthcare10020278
|